Castleark Management’s Bristol-Myers Squibb BMY Stock Holding History

Castleark Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-423,260	Closed	-$22.8M	–	380
2016 Q3	$22.8M	Sell	423,260 -229,310	-35%	-$14.7M	0.69%	38
2016 Q2	$48M	Buy	652,570 +76,990	+13%	+$5.44M	1.53%	9
2016 Q1	$36.8M	Sell	575,580 -172,820	-23%	-$10.9M	1.15%	26
2015 Q4	$51.5M	Buy	748,400 +355,090	+90%	+$23.5M	1.55%	10
2015 Q3	$23.3M	Buy	+393,310	New	+$25M	0.75%	35
2015 Q2	–	Sell	-27,700	Closed	-$1.79M	–	375
2015 Q1	$1.79M	Buy	27,700 +15,100	+120%	+$945K	0.04%	271
2014 Q4	$744K	Buy	+12,600	New	+$711K	0.02%	277
2013 Q4	–	Sell	-12,100	Closed	-$619K	–	322
2013 Q3	$619K	Buy	+12,100	New	+$531K	0.02%	272

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Castleark Management's BMY Position: Q4 2016 in Review

Castleark Management sold out of Bristol-Myers Squibb (BMY) in Q4 2016, closing a stake of 423,260 shares — an estimated $22.8M sold.

Castleark Management first reported a position in BMY in Q3 2013 and held it in 8 quarters. The position peaked at $51.5M in Q4 2015. 1,602 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

Castleark Management reported no remaining Bristol-Myers Squibb position as of Q4 2016 after selling out during the quarter.
Castleark Management sold 423,260 Bristol-Myers Squibb shares in Q4 2016, an estimated $22.8M.
Castleark Management first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 8 quarters.
Castleark Management's Bristol-Myers Squibb position peaked at $51.5M in Q4 2015.
1,602 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on Castleark Management's 13F filing for Q4 2016, filed 15 Feb 2017.